H3Africa: current perspectives.

Journal: Pharmacogenomics and personalized medicine

Volume: 11

Issue: 

Year of Publication: 

Affiliated Institutions:  Computational Biology Division, Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa. International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria. Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA. Department of Medicine, University of Cape Town, Cape Town, South Africa. Advanced Courses and Scientific Conferences, Wellcome Genome Campus, Hinxton, UK. Federal Teaching Hospital, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, Nigeria. Sydney Brenner Institute for Molecular Bioscience, Division of Human Genetics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg. Department of Psychiatry and Mental Health, University of Cape Town.

Abstract summary 

Precision medicine is being enabled in high-income countries by the growing availability of health data, increasing knowledge of the genetic determinants of disease and variation in response to treatment (pharmacogenomics), and the decreasing costs of data generation, which promote routine application of genomic technologies in the health sector. However, there is uncertainty about the feasibility of applying precision medicine approaches in low- and middle-income countries, due to the lack of population-specific knowledge, skills, and resources. The Human Heredity and Health in Africa (H3Africa) initiative was established to drive new research into the genetic and environmental basis for human diseases of relevance to Africans as well as to build capacity for genomic research on the continent. Precision medicine requires this capacity, in addition to reference data on local populations, and skills to analyze and interpret genomic data from the bedside. The H3Africa consortium is collectively processing samples and data for over 70,000 participants across the continent, accompanied in most cases by rich clinical information on a variety of non-communicable and infectious diseases. These projects are increasingly providing novel insights into the genetic basis of diseases in indigenous populations, insights that have the potential to drive the development of new diagnostics and treatments. The consortium has also invested significant resources into establishing high-quality biorepositories in Africa, a bioinformatic network, and a strong training program that has developed skills in genomic data analysis and interpretation among bioinformaticians, wet-lab researchers, and health-care professionals. Here, we describe the current perspectives of the H3Africa consortium and how it can contribute to making precision medicine in Africa a reality.

Authors & Co-authors:  Mulder Nicola N Abimiku Alash'le A Adebamowo Sally N SN de Vries Jantina J Matimba Alice A Olowoyo Paul P Ramsay Michele M Skelton Michelle M Stein Dan J DJ

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Biankin AV. The road to precision oncology. Nat Genet. 2017;49(3):320–321.
Authors :  9
Identifiers
Doi : 10.2147/PGPM.S141546
SSN : 1178-7066
Study Population
Male,Female
Mesh Terms
Other Terms
H3Africa;disease;genomic medicine;population genetics;precision medicine;training
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
New Zealand